Given how common TRD can be, limits in medication solutions — ordinarily an important ingredient of depression treatment designs — are a significant roadblock. Nevertheless, There is certainly hope.Ketamine also has clinically significant interactions with other receptors, but these are typically mostly weaker than its NMDA receptor antagonism.